0,770  0,002  GABA C receptor rho-3 antagonist
0,648  0,005  Dyrk kinase inhibitor
0,632  0,005  Ca2+/calmodulin-dependent protein kinase inhibitor
0,609  0,005  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,586  0,004  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,592  0,023  Antineoplastic (solid tumors)
0,570  0,002  GABA C receptor rho-2 antagonist
0,570  0,005  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,565  0,004  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,559  0,005  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,571  0,018  Anxiolytic
0,556  0,013  Antineoplastic (non-small cell lung cancer)
0,545  0,005  Antineoplastic (bladder cancer)
0,571  0,034  Antineoplastic (lung cancer)
0,557  0,028  Antineoplastic (colorectal cancer)
0,550  0,027  Antineoplastic (colon cancer)
0,522  0,021  CYP1A2 substrate
0,500  0,030  Antineoplastic (myeloid leukemia)
0,490  0,029  5 Hydroxytryptamine release stimulant
0,467  0,018  Hypoxia-inducible factor 1 alpha inhibitor
0,453  0,006  Glycogen synthase kinase-3 inhibitor
0,469  0,026  Antineoplastic (cervical cancer)
0,446  0,013  Antineoplastic (small cell lung cancer)
0,464  0,033  Ulceration
0,437  0,006  DNA intercalator
0,427  0,004  Aldehyde oxidase substrate
0,465  0,046  Antileukemic
0,476  0,058  Alzheimer's disease treatment
0,463  0,053  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,438  0,031  Aryl hydrocarbon receptor agonist
0,470  0,066  MAP kinase 1 inhibitor
0,405  0,007  Glycogen synthase kinase-3 beta inhibitor
0,412  0,026  DNA damaging
0,398  0,016  Antineoplastic (sarcoma)
0,378  0,004  Protein kinase C zeta inhibitor
0,423  0,055  CYP2C9 substrate
0,361  0,004  Protein kinase C gamma inhibitor
0,380  0,022  Clk dual-specificity kinase inhibitor
0,410  0,053  MAP kinase kinase 6 inhibitor
0,364  0,008  MAP-kinase-activated kinase 5 inhibitor
0,367  0,012  Pneumotoxic
0,354  0,007  Topoisomerase I inhibitor
0,363  0,018  MAP kinase kinase 2 inhibitor
0,386  0,050  FMO1 substrate
0,339  0,003  GABA C receptor rho-1 antagonist
0,339  0,004  Antiprotozoal (Babesia)
0,338  0,005  Protein kinase A inhibitor
0,340  0,008  Cyclin-dependent kinase 7 inhibitor
0,355  0,023  Antiparkinsonian, rigidity relieving
0,327  0,008  CDC-like kinase 1 inhibitor
0,356  0,039  Radiosensitizer
0,362  0,046  CYP3A4 inhibitor
0,320  0,010  Toll-Like receptor 9 antagonist
0,340  0,032  Antineoplastic (lymphocytic leukemia)
0,377  0,069  CYP2C9 inhibitor
0,318  0,012  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,308  0,004  Protein kinase C alpha inhibitor
0,307  0,004  GABA C receptor antagonist
0,339  0,042  FMO3 substrate
0,299  0,004  GABA A receptor antagonist
0,372  0,078  CYP2C19 inhibitor
0,315  0,021  Protein kinase C nu inhibitor
0,316  0,024  Antimigraine
0,300  0,015  Cytokine production inhibitor
0,344  0,062  Immunomodulator
0,305  0,023  Ca2+/calmodulin-dependent kinase IV inhibitor
0,286  0,004  GABA receptor antagonist
0,351  0,071  Antiprotozoal (Plasmodium)
0,336  0,058  Nootropic
0,344  0,068  Mood disorders treatment
0,319  0,045  Antineoplastic (lymphoma)
0,315  0,044  Pyruvate kinase inhibitor
0,315  0,046  Antineoplastic (renal cancer)
0,272  0,004  Bromodomain-containing protein 4 inhibitor
0,328  0,061  Antineoplastic (brain cancer)
0,299  0,038  Death-associated protein kinase 3 inhibitor
0,309  0,050  Cytostatic
0,277  0,023  Cyclin-dependent kinase inhibitor
0,306  0,052  Antiprotozoal (Leishmania)
0,274  0,021  Topoisomerase II inhibitor
0,274  0,021  Glycogen synthase kinase-3 alpha inhibitor
0,278  0,027  LIM domain kinase 1 inhibitor
0,261  0,009  GABA receptor agonist
0,256  0,005  Photosensitizer
0,319  0,070  Antidepressant
0,299  0,052  Antineoplastic (liver cancer)
0,309  0,065  Antineoplastic (pancreatic cancer)
0,258  0,014  Cyclin-dependent kinase 3 inhibitor
0,340  0,097  Antiprotozoal
0,252  0,009  Telomerase inhibitor
0,279  0,036  TRKC antagonist
0,247  0,005  Protein kinase C delta inhibitor
0,256  0,014  Butyrylcholinesterase inhibitor
0,285  0,044  Gastrin inhibitor
0,296  0,056  Flavin-containing monooxygenase substrate
0,243  0,003  Protein kinase C eta inhibitor
0,243  0,005  Antineoplastic alkaloid
0,252  0,015  Cyclin-dependent kinase 8 inhibitor
0,273  0,038  CDC-like kinase 2 inhibitor
0,303  0,069  Antineoplastic (melanoma)
0,284  0,052  Antineoplastic (glioblastoma multiforme)
0,279  0,050  Antimitotic
0,315  0,093  CYP3A4 substrate
0,231  0,010  Obsessive-compulsive disorder treatment
0,289  0,069  Aldehyde oxidase inhibitor
0,259  0,040  Antialcoholic
0,239  0,023  Activin receptor-like kinase 2 inhibitor
0,219  0,005  5 Hydroxytryptamine 3 antagonist
0,215  0,003  Bromodomain-containing protein 2 inhibitor
0,222  0,011  Pim-1 kinase inhibitor
0,309  0,100  Cognition disorders treatment
0,352  0,144  Caspase 9 stimulant
0,273  0,066  Antineoplastic (glioma)
0,221  0,015  Antiprotozoal (Trichomonas)
0,292  0,086  CYP2D6 substrate
0,281  0,075  CYP2C19 substrate
0,275  0,070  CYP1A2 inhibitor
0,263  0,061  5 Hydroxytryptamine 1E antagonist
0,218  0,018  MAP kinase 12 inhibitor
0,343  0,143  Apoptosis agonist
0,280  0,081  Antineoplastic (ovarian cancer)
0,285  0,087  Caspase 3 stimulant
0,271  0,073  GST M1-1 substrate
0,198  0,003  Protein kinase C beta inhibitor
0,309  0,114  Antineoplastic (breast cancer)
0,256  0,062  Tyrosine 3 hydroxylase inhibitor
0,242  0,049  CDC-like kinase 4 inhibitor
0,235  0,045  CYP2B6 inhibitor
0,202  0,012  Protein kinase C mu inhibitor
0,252  0,063  Cyclic AMP phosphodiesterase inhibitor
0,308  0,119  Histamine release inhibitor
0,208  0,021  Cyclin-dependent kinase 5 inhibitor
0,215  0,027  Bipolar disorder treatment
0,281  0,094  Prostate cancer treatment
0,216  0,029  Acetylcholinesterase inhibitor
0,218  0,034  CNS active muscle relaxant
0,220  0,036  5 Hydroxytryptamine 3E antagonist
0,211  0,029  Interleukin 1 antagonist
0,230  0,049  I kappa B kinase epsilon inhibitor
0,280  0,100  Apoptosis antagonist
0,194  0,014  Interleukin 8 antagonist
0,184  0,004  Protein kinase C epsilon inhibitor
0,199  0,021  MAP kinase 13 inhibitor
0,193  0,015  NAT2 substrate
0,187  0,011  GABA A receptor agonist
0,207  0,032  ATPase inhibitor
0,225  0,051  Focal adhesion kinase 2 inhibitor
0,212  0,041  Cholinergic
0,194  0,024  Ferrochelatase inhibitor
0,173  0,005  Protein kinase B beta inhibitor
0,180  0,013  Prolactin inhibitor
0,172  0,005  Caspase 7 inhibitor
0,208  0,041  Polo-like kinase-3 inhibitor
0,201  0,035  Phosphodiesterase inhibitor
0,175  0,009  Cyclin B3 inhibitor
0,239  0,074  DNA synthesis inhibitor
0,229  0,063  Antiviral (West Nile virus)
0,197  0,032  Toll-Like receptor antagonist
0,203  0,039  Interleukin 6 antagonist
0,208  0,045  VEGF expression inhibitor
0,204  0,041  Antiparkinsonian, tremor relieving
0,219  0,058  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,178  0,019  Activin receptor-like kinase 4 inhibitor
0,180  0,021  Polo-like kinase-4 inhibitor
0,190  0,033  Sodium channel (voltage-gated) blocker
0,182  0,025  MAP3K9 inhibitor
0,182  0,026  Cyclin-dependent kinase 9 inhibitor
0,223  0,068  MAP kinase kinase 3 inhibitor
0,206  0,051  Antiviral (Ebola)
0,169  0,014  Phosphodiesterase I inhibitor
0,156  0,004  Cyclin D1 inhibitor
0,191  0,039  Tyrosine-protein kinase receptor FLT3 inhibitor
0,177  0,026  MAP kinase kinase 4 inhibitor
0,156  0,005  Potassium channel (Ca-activated) blocker
0,200  0,052  Antineoplastic (gastric cancer)
0,212  0,063  DNA methyltransferase I inhibitor
0,220  0,073  RNA-directed DNA polymerase inhibitor
0,158  0,012  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,238  0,094  5 Hydroxytryptamine uptake stimulant
0,210  0,067  Sedative
0,173  0,030  Cyclin-dependent kinase 2 inhibitor
0,175  0,032  5 Hydroxytryptamine 2B antagonist
0,147  0,005  5 Hydroxytryptamine 3A antagonist
0,146  0,004  5 Hydroxytryptamine 3B antagonist
0,194  0,053  Heat shock protein 90 alpha antagonist
0,151  0,010  Cyclin E inhibitor
0,185  0,046  Skeletal muscle relaxant
0,207  0,069  Osteoarthritis treatment
0,213  0,074  Anticonvulsant
0,153  0,015  Acetylcholine release stimulant
0,145  0,009  Benzodiazepine agonist
0,154  0,021  Myasthenia Gravis treatment
0,142  0,008  5 Hydroxytryptamine 5A antagonist
0,149  0,017  Interleukin 1 beta converting enzyme inhibitor
0,185  0,054  Antineoplastic (bone cancer)
0,149  0,018  Pim-3 kinase inhibitor
0,134  0,004  Antidote, organophosphates
0,139  0,009  5 Hydroxytryptamine 5 antagonist
0,178  0,048  Ribosomal protein S6 kinase inhibitor
0,153  0,024  Sphingosine 1-phosphate receptor 2 agonist
0,138  0,010  Cyclin E1 inhibitor
0,205  0,076  DNA methylase inhibitor
0,174  0,047  Tubulin antagonist
0,225  0,098  Interleukin agonist
0,167  0,043  5 Hydroxytryptamine antagonist
0,166  0,043  MAP kinase kinase inhibitor
0,160  0,037  Cyclin-dependent kinase 1 inhibitor
0,128  0,005  Potassium channel small-conductance Ca-activated blocker
0,231  0,111  Antineoplastic (multiple myeloma)
0,190  0,070  Interleukin-1 receptor-associated protein kinase 1 inhibitor
0,174  0,055  Antineoplastic (carcinoma)
0,150  0,031  DNA repair enzyme inhibitor
0,139  0,021  Polo-like kinase-1 inhibitor
0,139  0,021  MAP kinase kinase 1 inhibitor
0,209  0,093  Antiamyloidogenic
0,135  0,019  5 Hydroxytryptamine 1F antagonist
0,136  0,020  CYP2A6 inhibitor
0,222  0,108  Antipsychotic
0,259  0,146  Antineoplastic (non-Hodgkin's lymphoma)
0,172  0,059  Neurotensin receptor agonist
0,133  0,021  Histamine N-methyltransferase inhibitor
0,125  0,015  Nav1.7 sodium channel blocker
0,136  0,027  CDC-like kinase 3 inhibitor
0,113  0,004  Cyclin E2 inhibitor
0,142  0,034  Fibroblast growth factor 1 antagonist
0,216  0,108  UGT1A9 substrate
0,114  0,007  Cyclin B2 inhibitor
0,227  0,120  Antihypoxic
0,136  0,030  5 Hydroxytryptamine 2C antagonist
0,165  0,059  Heat shock protein 90 antagonist
0,160  0,054  MAP kinase 3 inhibitor
0,151  0,046  TRKB antagonist
0,199  0,095  UGT1A6 substrate
0,112  0,009  Cyclin B1 inhibitor
0,197  0,095  Potassium channel blocker
0,120  0,018  Protein kinase B alpha inhibitor
0,142  0,041  MAP kinase 9 inhibitor
0,120  0,020  Syk tyrosine kinase inhibitor
0,163  0,064  Carcinogenic, group 1
0,124  0,025  Antidote, mercury
0,157  0,059  Hearing loss treatment
0,183  0,085  Non-steroidal antiinflammatory agent
0,117  0,019  Cyclin-dependent kinase 4 inhibitor
0,103  0,006  MAP kinase 7 inhibitor
0,172  0,074  Muscle relaxant
0,106  0,009  Cyclin B inhibitor
0,125  0,028  Topoisomerase II alpha inhibitor
0,185  0,089  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,134  0,039  Nav1.5 sodium channel blocker
0,206  0,111  Superoxide dismutase inhibitor
0,146  0,051  Antihelmintic (Trematoda)
0,134  0,040  Protein kinase (CK2) inhibitor
0,101  0,007  5 Hydroxytryptamine 7 agonist
0,097  0,003  Protein kinase C beta II inhibitor
0,106  0,013  5 Hydroxytryptamine 6 antagonist
0,123  0,030  Leucine-rich repeat kinase 2 inhibitor
0,153  0,060  RET inhibitor
0,142  0,049  Platelet activating factor antagonist
0,183  0,090  Psychostimulant
0,102  0,010  Cyclin-dependent kinase 6 inhibitor
0,101  0,010  Glutamate (mGluR7) antagonist
0,128  0,038  CDK/cyclin complex inhibitor
0,140  0,050  Antiprotozoal (Amoeba)
0,168  0,079  Mutagenic
0,147  0,058  Pregnane X receptor agonist
0,183  0,094  Neurotrophic factor enhancer
0,094  0,006  Bromodomain-containing protein 3 inhibitor
0,148  0,059  Sodium channel blocker
0,188  0,100  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,117  0,030  NAD(P)H dehydrogenase (quinone) inhibitor
0,114  0,028  p38 MAP kinase inhibitor
0,112  0,025  Histamine H2 receptor antagonist
0,130  0,044  Transcription factor STAT6 inhibitor
0,144  0,059  Ca2+-transporting ATPase inhibitor
0,107  0,022  Cyclin A2 inhibitor
0,162  0,077  Muscular dystrophy treatment
0,152  0,067  Protein kinase (CK1) gamma 1 inhibitor
0,103  0,019  Toll-Like receptor 7 antagonist
0,105  0,021  Cyclin A inhibitor
0,161  0,079  UGT1A4 substrate
0,128  0,046  Platelet activating factor beta antagonist
0,134  0,052  Protein kinase (CK2) alpha inhibitor
0,110  0,030  Glutamate release inhibitor
0,135  0,054  Aurora-B kinase inhibitor
0,130  0,049  Aurora-A kinase inhibitor
0,129  0,049  Carcinogenic, group 2B
0,095  0,016  Pim-2 kinase inhibitor
0,094  0,016  Phosphodiesterase 4C inhibitor
0,115  0,037  Carcinogenic, group 2A
0,119  0,042  Creatine kinase inhibitor
0,169  0,091  Systemic lupus erythematosus treatment
0,100  0,023  5 Hydroxytryptamine 1D antagonist
0,144  0,067  Tyrosine-protein kinase receptor antagonist
0,146  0,069  Vascular endothelial growth factor 3 antagonist
0,100  0,023  5 Hydroxytryptamine 1B antagonist
0,126  0,050  MAO A inhibitor
0,086  0,010  5 Hydroxytryptamine 1B agonist
0,109  0,033  Phosphodiesterase 4D inhibitor
0,110  0,035  ErbB-3 antagonist
0,147  0,072  Growth factor antagonist
0,128  0,054  5 Hydroxytryptamine 2 antagonist
0,159  0,085  Tyrosine kinase inhibitor
0,159  0,086  Death-associated protein kinase 2 inhibitor
0,099  0,026  Phosphodiesterase 4B inhibitor
0,104  0,031  Janus tyrosine kinase 3 inhibitor
0,076  0,005  Benzodiazepine antagonist
0,117  0,047  Antiemetic
0,133  0,062  Antismoking
0,101  0,032  Protein kinase B gamma inhibitor
0,074  0,005  Antiviral (Bovine viral diarrhea virus)
0,094  0,024  Transforming growth factor antagonist
0,137  0,069  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,108  0,040  Arylamine N-Acetyltransferase substrate
0,075  0,008  Benzodiazepine inverse agonist
0,091  0,023  MAP kinase kinase 7 inhibitor
0,088  0,021  5 Hydroxytryptamine 3 agonist
0,174  0,107  Histone acetyltransferase inhibitor
0,069  0,003  Protein kinase C beta I inhibitor
0,079  0,013  Cholecystokinin A antagonist
0,203  0,137  UGT2B4 substrate
0,290  0,224  Antiinflammatory
0,103  0,037  MAP-kinase-activated kinase inhibitor
0,100  0,035  MAP kinase 10 inhibitor
0,079  0,015  Protein kinase C theta inhibitor
0,080  0,016  Phosphodiesterase 1A inhibitor
0,139  0,076  Protein kinase (CK1) inhibitor
0,080  0,017  Corticotropin releasing factor 2 receptor antagonist
0,094  0,032  MAP-kinase-activated kinase 2 inhibitor
0,119  0,057  5 Hydroxytryptamine 3A agonist
0,070  0,007  Alpha 1d adrenoreceptor agonist
0,139  0,077  Heat shock protein 70 antagonist
0,096  0,034  D-Ala-D-Ala ligase inhibitor
0,075  0,013  Cholecystokinin antagonist
0,081  0,020  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,160  0,099  Cytotoxic
0,110  0,050  CDK2/cyclin A inhibitor
0,124  0,066  Vascular endothelial growth factor antagonist
0,096  0,038  MAP kinase 11 inhibitor
0,076  0,019  mTOR inhibitor
0,072  0,016  Topoisomerase II beta inhibitor
0,072  0,016  Phosphodiesterase X inhibitor
0,072  0,016  Phosphodiesterase 10A inhibitor
0,152  0,096  UGT2B10 substrate
0,108  0,052  Hedgehog signaling inhibitor
0,173  0,118  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,119  0,063  Interleukin 1b antagonist
0,091  0,036  Transforming growth factor beta 3 antagonist
0,097  0,043  Histamine H1 receptor antagonist
0,124  0,070  Protein kinase (CK1) delta inhibitor
0,189  0,136  Huntington's disease treatment
0,058  0,004  Estrogen-related receptor beta antagonist
0,096  0,042  ErbB-4 antagonist
0,110  0,058  MAP kinase kinase kinase inhibitor
0,091  0,039  Fibroblast growth factor 3 antagonist
0,155  0,103  LDLR expression enhancer
0,091  0,039  Nicotinic alpha4beta2 receptor antagonist
0,070  0,019  VEGFR2 expression inhibitor
0,069  0,018  5 Hydroxytryptamine 4 antagonist
0,114  0,063  Cystathionine beta-synthase inhibitor
0,140  0,090  Antinephritic
0,118  0,069  TRKA antagonist
0,113  0,064  Vascular endothelial growth factor 2 antagonist
0,072  0,024  Phosphodiesterase 4A inhibitor
0,071  0,023  Toll-Like receptor 8 antagonist
0,070  0,022  Cyclin A1 inhibitor
0,084  0,036  Check point kinase 1 inhibitor
0,092  0,045  TIE-2 antagonist
0,070  0,023  Prolactin release inhibitor
0,111  0,065  Alpha 2b adrenoreceptor antagonist
0,093  0,047  TIE antagonist
0,162  0,116  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,210  0,164  Vasodilator, peripheral
0,139  0,093  Neuropathy treatment
0,066  0,021  Lysine-specific demethylase 1A inhibitor
0,216  0,170  GST A substrate
0,054  0,009  Retinoid X receptor antagonist
0,150  0,105  Lipocortins synthesis antagonist
0,083  0,039  Adenosine A3 receptor antagonist
0,196  0,152  CYP2D6 inhibitor
0,079  0,036  CDC7 inhibitor
0,083  0,041  Polo-like kinase-2 inhibitor
0,057  0,015  Premature ejaculation treatment
0,107  0,066  Excitatory amino acid transporter EAAC1 inhibitor
0,092  0,051  Phosphodiesterase IV inhibitor
0,069  0,028  Fibroblast growth factor 4 antagonist
0,086  0,045  Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor
0,114  0,074  Carcinogenic, group 3
0,047  0,008  Retinoid X alpha receptor antagonist
0,198  0,159  Insulysin inhibitor
0,177  0,139  Spasmolytic
0,091  0,053  Tocolytic
0,046  0,009  Protein kinase (CK2) beta inhibitor
0,069  0,032  CDK9/cyclin T1 inhibitor
0,099  0,062  MAP kinase 8 inhibitor
0,129  0,093  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,077  0,041  CDK1/cyclin B1 inhibitor
0,177  0,142  Antiprotozoal (Trypanosoma)
0,068  0,033  Phosphodiesterase 1B inhibitor
0,073  0,039  Fibroblast growth factor 2 antagonist
0,046  0,012  Potassium channel small-conductance Ca-activated activator
0,043  0,010  ATR kinase inhibitor
0,068  0,036  CDK2/cyclin E inhibitor
0,043  0,011  Benzodiazepine receptor peripheral-type antagonist
0,055  0,023  Histamine H4 receptor antagonist
0,058  0,026  AMPA receptor antagonist
0,079  0,048  Porphobilinogen synthase inhibitor
0,180  0,149  Respiratory analeptic
0,155  0,126  HERG channel blocker
0,147  0,117  Anesthetic general
0,106  0,077  CDK3/cyclin E inhibitor
0,038  0,009  5 Hydroxytryptamine 6 agonist
0,069  0,041  Adenosine A2 receptor antagonist
0,082  0,054  Phosphodiesterase XI inhibitor
0,082  0,054  Phosphodiesterase 11A inhibitor
0,112  0,084  Contraceptive female
0,250  0,223  Autoimmune disorders treatment
0,063  0,036  Heat shock protein 90 beta antagonist
0,063  0,037  Adenosine A1 receptor antagonist
0,071  0,046  I kappa B kinase 1 inhibitor
0,074  0,049  S-adenosyl-L-methionine decarboxylase inhibitor
0,081  0,056  Platelet growth factor antagonist
0,068  0,043  Antihemophilic
0,142  0,117  Wound healing agent
0,051  0,027  Cytokine production stimulant
0,037  0,014  Calcitonin gene-related peptide antagonist
0,117  0,093  Antineoplastic (squamous cell carcinoma)
0,085  0,062  Granulocyte macrophage colony stimulating factor agonist
0,152  0,128  EphB2 antagonist
0,047  0,024  Histamine H1 receptor agonist
0,063  0,041  Phosphodiesterase 1C inhibitor
0,074  0,052  Rho-associated kinase inhibitor
0,105  0,083  Alkylator
0,093  0,072  Antifungal (Candida)
0,135  0,114  Antiviral (Hepatitis C)
0,099  0,078  GST T1-1 substrate
0,083  0,062  mTOR complex 2 inhibitor
0,046  0,025  GABA B receptor antagonist
0,149  0,128  Antirickettsial
0,176  0,156  Proliferative diseases treatment
0,084  0,065  Falcipain 2 inhibitor
0,065  0,045  Aryl hydrocarbon receptor antagonist
0,062  0,043  Adenosine A2a receptor antagonist
0,081  0,061  Antiviral (RSV)
0,128  0,109  Irritable Bowel syndrome treatment
0,083  0,063  Insulin growth factor antagonist
0,099  0,080  SULT1A1 substrate
0,085  0,067  Falcipain inhibitor
0,065  0,047  Uterine relaxant
0,093  0,076  Antiviral (Poxvirus)
0,079  0,062  Insulin like growth factor 1 antagonist
0,092  0,074  Insulin receptor antagonist
0,084  0,067  NADH dehydrogenase inhibitor
0,117  0,100  Nav1.6 sodium channel blocker
0,075  0,058  Macrophage migration inhibitory factor inhibitor
0,102  0,087  Beta amyloid protein antagonist
0,077  0,061  5 Hydroxytryptamine 2A antagonist
0,019  0,004  Corticotropin releasing factor antagonist
0,060  0,046  Prostaglandin F2 alpha antagonist
0,193  0,178  Angiogenesis inhibitor
0,063  0,049  Phosphodiesterase III inhibitor
0,051  0,037  Phosphatidylinositol 3-kinase alpha inhibitor
0,094  0,080  Granulocyte macrophage colony stimulating factor antagonist
0,076  0,062  Phosphodiesterase 3A inhibitor
0,032  0,018  5 Hydroxytryptamine 1D agonist
0,115  0,102  UGT2B15 substrate
0,117  0,103  Peroxidase inhibitor
0,058  0,045  Potassium channel intermediate-conductance Ca-activated blocker
0,104  0,092  Epidermal growth factor receptor kinase inhibitor
0,027  0,016  5 Hydroxytryptamine 1F agonist
0,068  0,057  Janus tyrosine kinase 2 inhibitor
0,037  0,026  Delayed rectifier potassium channel blocker
0,056  0,045  Phosphatidylinositol kinase inhibitor
0,112  0,101  Antifungal enhancer
0,119  0,108  Aurora-C kinase inhibitor
0,074  0,063  Interferon agonist
0,058  0,048  CDK1/cyclin B inhibitor
0,076  0,067  AXL receptor tyrosine kinase inhibitor
0,068  0,058  MAP3K7 inhibitor
0,021  0,012  Inosine monophosphate dehydrogenase 2 inhibitor
0,020  0,011  Cyclin T1 inhibitor
0,047  0,038  Transforming growth factor beta 1 antagonist
0,141  0,132  UGT1A1 substrate
0,069  0,061  Cushing's syndrome treatment
0,044  0,035  Purinergic P2X4 antagonist
0,123  0,114  UGT2B9 substrate
0,042  0,034  Geranyltranstransferase inhibitor
0,108  0,100  Antimutagenic
0,035  0,027  Inosine monophosphate dehydrogenase inhibitor
0,131  0,123  Movement disorders treatment
0,085  0,078  Anticataract
0,119  0,112  Genotoxic
0,046  0,039  Adenosine A2b receptor antagonist
0,048  0,042  Aconitate hydratase inhibitor
0,018  0,011  Vesicular glutamate transport inhibitor
0,056  0,049  5 Hydroxytryptamine 7 antagonist
0,088  0,082  GABA C receptor agonist
0,155  0,149  Antipyretic
0,114  0,108  Cytidine deaminase inhibitor
0,165  0,159  Analeptic
0,123  0,119  Antifungal (Cryptococcus)
0,074  0,070  I kappa B kinase inhibitor
0,011  0,007  CD80 antagonist
0,085  0,081  Alpha 2c adrenoreceptor antagonist
0,072  0,068  Xanthine oxidase substrate
0,135  0,131  3C-like protease (Human coronavirus) inhibitor
0,049  0,046  Nicotinic receptor alpha7 subunit antagonist
0,053  0,049  Protein kinase C iota inhibitor
0,059  0,056  Acetylcholine M5 receptor agonist
0,078  0,075  Antileprosy
0,020  0,018  Geranylgeranyltransferase inhibitor
0,095  0,092  Antifungal (Aspergillus)
0,071  0,069  Acetylcholine nicotinic agonist
0,075  0,073  Epidermal growth factor antagonist
0,142  0,140  Phobic disorders treatment
0,050  0,049  CDK4/cyclin D1 inhibitor
0,045  0,044  5 Hydroxytryptamine 2 agonist
0,059  0,057  Interferon inducer
0,049  0,048  Phosphatidylinositol 3-kinase delta inhibitor
0,030  0,029  Antihyperaldosteronism
0,047  0,047  Nicotinic alpha7 receptor agonist

